Harrow: Q4 Financial Overview

Harrow, Inc. Announces Fourth-Quarter Financial Results

Harrow, Inc., headquartered in Nashville, Tennessee, disclosed its financial performance for the fourth quarter on Monday, reporting a net profit of $6.6 million.

The company achieved earnings of 17 cents per share, while adjusted earnings—excluding amortization expenses—stood at 26 cents per share.

These figures fell short of analysts’ expectations, as a consensus from three Zacks Investment Research analysts had projected earnings of 40 cents per share.

Despite the earnings miss, Harrow, which specializes in pharmaceuticals and drug compounding, generated $89.1 million in revenue for the quarter, surpassing the $88.8 million anticipated by analysts surveyed by Zacks.

Looking at the full year, Harrow reported a net loss of $5.1 million, or 14 cents per share, with total revenue reaching $272.3 million.

This article was produced by Automated Insights using data provided by Zacks Investment Research.